The autologous platelet concentrates for maxillary sinus floor elevation: an overview of systematic reviews

doi:10.12337/zgkqzzxzz.2023.04.006

Abstract

Abstract: Objective To evaluate the quality of methodology and evidence of the systematic reviews and meta-analyses (SR/MA) of autologous platelet concentrates (APC) for maxillary sinus floor elevation (MSFE). Methods PubMed, Embase, Cochrane Library, Scopus, CNKI, SinoMed, and WanFang databases were electronically searched to enroll SR/MA of APC for MSFE from inception to August 31, 2022. Two reviewers independently screened literature, extracted data, and employed the AMSTAR 2 and the GRADE for evaluating the quality of methodology of the included studies and the certainty of the evidence for outcomes respectively. Results A total of 13 SR/MA were included and the major conclusions were that APC presents limited influence on MSFE and might promote the healing of sinus tissue. The 9 items of AMSTAR 2 were reported well, and two items were not reported in any of the included SRs, and the quality was relatively convinced. The evidence grading of GRADE revealed that, in the total of 46 outcomes, 9 were graded as high-level, 25 as medium-level, 11 as low-level, and 1 as extremely low-level. Conclusion Most of the current evidence shows the advantages of APC in MSFE are not obvious, but the reliability of SR/Ma is inconsistent. High-quality clinical trials are still needed to verify the efficacy of APC for MSFE

Key words: Autologous platelet, Maxillary sinus floor elevation, Clinical trials, Overview of systematic reviews, AMSTAR 2, GRADE

Gong Jiaming, Zhao Ruimin, Zhang Qihang, Yu Zhanhai, Su Linhan. The autologous platelet concentrates for maxillary sinus floor elevation: an overview of systematic reviews[J]. Chinese Journal of Oral Implantology, 2023, 28(2): 102-108.

References

[1] Demirkol M, Demirkol N.The effects of posterior alveolar bone height on the height of maxillary sinus septa[J]. Surg Radiol Anat, 2019,41(9):1003-1009. DOI: 10.1007/s00276-019-02271-2.
[2] Khehra A, Levin L.Maxillary sinus augmentation procedures: a narrative clinical review[J]. Quintessence Int, 2020,51(7):578-584. DOI: 10.3290/j.qi.a44632.
[3] Stumbras A, Krukis MM, Januzis G, et al.Regenerative bone potential after sinus floor elevation using various bone graft materials: a systematic review[J]. Quintessence Int, 2019,50(7):548-558. DOI: 10.3290/j.qi.a42482.
[4] Kim TH, Kim SH, Sándor GK, et al.Comparison of platelet-rich plasma (PRP), platelet-rich fibrin (PRF), and concentrated growth factor (CGF) in rabbit-skull defect healing[J]. Arch Oral Biol, 2014,59(5):550-558. DOI: 10.1016/j.archoralbio.2014.02.004.
[5] Adalı E, Yüce MO, Günbay T, et al.Does concentrated growth factor used with allografts in maxillary sinus lifting have adjunctive benefits?[J]. J Oral Maxillofac Surg, 2021,79(1):98-108. DOI: 10.1016/j.joms.2020.07.217.
[6] de Almeida Barros Mourão CF, Lourenço ES, Nascimento J, et al. Does the association of blood-derived growth factors to nanostructured carbonated hydroxyapatite contributes to the maxillary sinus floor elevation? A randomized clinical trial[J]. Clin Oral Investig, 2019,23(1):369-379. DOI: 10.1007/s00784-018-2445-7.
[7] Trimmel B, Gyulai-Gaál S, Kivovics M, et al.Evaluation of the histomorphometric and micromorphometric performance of a serum albumin-coated bone allograft combined with a-PRF for early and conventional healing protocols after maxillary sinus augmentation: a randomized clinical trial[J]. Materials (Basel), 2021,14(7):1810. DOI: 10.3390/ma14071810.
[8] Attia S, Narberhaus C, Schaaf H, et al.Long-term influence of platelet-rich plasma (PRP) on dental implants after maxillary augmentation: retrospective clinical and radiological outcomes of a randomized controlled clinical trial[J]. J Clin Med, 2020,9(2):355. DOI: 10.3390/jcm9020355.
[9] Damsaz M, Castagnoli CZ, Eshghpour M, et al.Evidence-based clinical efficacy of leukocyte and platelet-rich fibrin in maxillary sinus floor lift, graft and surgical augmentation procedures[J]. Front Surg, 2020,7:537138. DOI: 10.3389/fsurg.2020.537138.
[10] Guo T, Gulati K, Shen Z, et al.Therapeutic outcomes of non-grafted and platelet concentrations-grafted transcrestal maxillary sinus elevation (tsfe): a systematic review and meta-analysis[J]. Sci Rep, 2020,10(1):5935. DOI: 10.1038/s41598-020-62407-y.
[11] Liu R, Yan M, Chen S, et al.Effectiveness of platelet-rich fibrin as an adjunctive material to bone graft in maxillary sinus augmentation: a meta-analysis of randomized controlled trails[J]. Biomed Res Int, 2019,2019:7267062. DOI: 10.1155/2019/7267062.
[12] Meng Y, Huang X, Wu M, et al.The effect of autologous platelet concentrates on maxillary sinus augmentation: a meta-analysis of randomized controlled trials and systematic review[J]. Biomed Res Int, 2020,2020:7589072. DOI: 10.1155/2020/7589072.
[13] 田金徽. 系统评价再评价撰写注意事项[J].中国药物评价,2019,36(1):1-4. DOI: 10.3969/j.issn.2095-3593.2019.01.001.
[14] 张方圆, 沈傲梅, 曾宪涛, 等. 系统评价方法学质量评价工具AMSTAR 2解读[J].中国循证心血管医学杂志, 2018,10(1):14-18. DOI: 10.3969/j.issn.1674-4055. 2018. 01.03.
[15] Gordon H Guyatt, Andrew D Oxman, Gunn E Vist,等. GRADE:证据质量和推荐强度分级的共识[J].中国循证医学杂志,2009,9(1):8-11. DOI: 10.3969/j.issn.1672-2531.2009.01.005.
[16] Arora NS, Ramanayake T, Ren YF, et al.Platelet-rich plasma in sinus augmentation procedures: a systematic literature review: part II[J]. Implant Dent, 2010,19(2):145-157. DOI: 10.1097/ID.0b013e3181cd706d.
[17] Bae JH, Kim YK, Myung SK.Effects of platelet-rich plasma on sinus bone graft: meta-analysis[J]. J Periodontol, 2011,82(5):660-667. DOI: 10.1902/jop.2010.100529.
[18] Del Fabbro M, Bortolin M, Taschieri S, et al.Effect of autologous growth factors in maxillary sinus augmentation: a systematic review[J]. Clin Implant Dent Relat Res, 2013,15(2):205-216. DOI: 10.1111/j.1708-8208.2011.00343.x.
[19] 于连聘. 血小板来源的生长因子在上颌窦提升中作用的Meta分析[D]. 山东大学, 2015.
[20] Lemos CA, Mello CC, dos Santos DM, et al. Effects of platelet-rich plasma in association with bone grafts in maxillary sinus augmentation: a systematic review and meta-analysis[J]. Int J Oral Maxillofac Surg, 2016,45(4):517-525. DOI: 10.1016/j.ijom.2015.07.012.
[21] Pocaterra A, Caruso S, Bernardi S, et al.Effectiveness of platelet-rich plasma as an adjunctive material to bone graft: a systematic review and meta-analysis of randomized controlled clinical trials[J]. Int J Oral Maxillofac Surg, 2016,45(8):1027-1034. DOI: 10.1016/j.ijom.2016.02.012.
[22] Ortega-Mejia H, Estrugo-Devesa A, Saka-Herrán C, et al.Platelet-rich plasma in maxillary sinus augmentation: systematic review[J]. Materials (Basel), 2020,13(3):622. DOI: 10.3390/ma13030622.
[23] 侯鑫山, 刘媛, 吴龙, 等. 富血小板血浆应用于上颌窦底提升术疗效的meta分析[J].医学信息,2020,33(20):69-72. DOI: 10.3969/j.issn.1006-1959.2020.20.019.
[24] Otero A, Fernandes J, Borges T, et al.Sinus lift associated with leucocyte-platelet-rich fibrin (second generation) for bone gain: a systematic review[J]. J Clin Med, 2022,11(7):1888. DOI: 10.3390/jcm11071888.
[25] 陈思宇. 上颌窦底提升术中应用PRF对骨再生的影响:随机对照试验的系统评价与Meta分析[D]. 吉林大学, 2022.
[26] 袁金秋, 刘雅莉, 杨克虎, 等. 系统评价再评价纳入研究的质量评价方法调查[J].中国循证医学杂志,2012, 12(2):238-242. DOI: 10.3969/j.issn.1672-2531.2012.02.018.
[27] Schulz KF, Altman DG, Moher D.CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials[J]. BMJ, 2010,340:c332. DOI: 10.1136/bmj.c332.
[28] Bettega G, Brun JP, Boutonnat J, et al.Autologous platelet concentrates for bone graft enhancement in sinus lift procedure[J]. Transfusion, 2009,49(4):779-785. DOI: 10.1111/j.1537-2995.2008.02036.x.